These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3198614)

  • 1. Heparin type IV collagen interactions: equilibrium binding and inhibition of type IV collagen self-assembly.
    Tsilibary EC; Koliakos GG; Charonis AS; Vogel AM; Reger LA; Furcht LT
    J Biol Chem; 1988 Dec; 263(35):19112-8. PubMed ID: 3198614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The binding of heparin to type IV collagen: domain specificity with identification of peptide sequences from the alpha 1(IV) and alpha 2(IV) which preferentially bind heparin.
    Koliakos GG; Kouzi-Koliakos K; Furcht LT; Reger LA; Tsilibary EC
    J Biol Chem; 1989 Feb; 264(4):2313-23. PubMed ID: 2914908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a multifunctional, cell-binding peptide sequence from the a1(NC1) of type IV collagen.
    Tsilibary EC; Reger LA; Vogel AM; Koliakos GG; Anderson SS; Charonis AS; Alegre JN; Furcht LT
    J Cell Biol; 1990 Oct; 111(4):1583-91. PubMed ID: 2211826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of nonenzymatic glucosylation on the binding of the main noncollagenous NC1 domain to type IV collagen.
    Tsilibary EC; Charonis AS; Reger LA; Wohlhueter RM; Furcht LT
    J Biol Chem; 1988 Mar; 263(9):4302-8. PubMed ID: 3346249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the main noncollagenous domain (NC1) in type IV collagen self-assembly.
    Tsilibary EC; Charonis AS
    J Cell Biol; 1986 Dec; 103(6 Pt 1):2467-73. PubMed ID: 3782304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping the heparin-binding sites on type I collagen monomers and fibrils.
    San Antonio JD; Lander AD; Karnovsky MJ; Slayter HS
    J Cell Biol; 1994 Jun; 125(5):1179-88. PubMed ID: 8195298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localization of binding sites for laminin, heparan sulfate proteoglycan and fibronectin on basement membrane (type IV) collagen.
    Laurie GW; Bing JT; Kleinman HK; Hassell JR; Aumailley M; Martin GR; Feldmann RJ
    J Mol Biol; 1986 May; 189(1):205-16. PubMed ID: 2946868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of type XI collagen-glycosaminoglycan interactions.
    Vaughan-Thomas A; Young RD; Phillips AC; Duance VC
    J Biol Chem; 2001 Feb; 276(7):5303-9. PubMed ID: 11084037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The C-terminal domain V of perlecan promotes beta1 integrin-mediated cell adhesion, binds heparin, nidogen and fibulin-2 and can be modified by glycosaminoglycans.
    Brown JC; Sasaki T; Göhring W; Yamada Y; Timpl R
    Eur J Biochem; 1997 Nov; 250(1):39-46. PubMed ID: 9431988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The C-terminus of type I collagen is a major binding site for heparin.
    Keller KM; Keller JM; Kühn K
    Biochim Biophys Acta; 1986 Jun; 882(1):1-5. PubMed ID: 3011107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping of three major heparin-binding sites on laminin and identification of a novel heparin-binding site on the B1 chain.
    Kouzi-Koliakos K; Koliakos GG; Tsilibary EC; Furcht LT; Charonis AS
    J Biol Chem; 1989 Oct; 264(30):17971-8. PubMed ID: 2808359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A network model for the organization of type IV collagen molecules in basement membranes.
    Timpl R; Wiedemann H; van Delden V; Furthmayr H; Kühn K
    Eur J Biochem; 1981 Nov; 120(2):203-11. PubMed ID: 6274634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure and interactions of heparan sulfate proteoglycans from a mouse tumor basement membrane.
    Fujiwara S; Wiedemann H; Timpl R; Lustig A; Engel J
    Eur J Biochem; 1984 Aug; 143(1):145-57. PubMed ID: 6236080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of laminin self-assembly and interaction with type IV collagen by antibodies to the terminal domain of the long arm.
    Charonis AS; Tsilibary EC; Saku T; Furthmayr H
    J Cell Biol; 1986 Nov; 103(5):1689-97. PubMed ID: 2430974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of osteogenin, a heparin binding bone morphogenetic protein, with type IV collagen.
    Paralkar VM; Nandedkar AK; Pointer RH; Kleinman HK; Reddi AH
    J Biol Chem; 1990 Oct; 265(28):17281-4. PubMed ID: 2211625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparan sulfate proteoglycans from mouse mammary epithelial cells. Basal extracellular proteoglycan binds specifically to native type I collagen fibrils.
    Koda JE; Bernfield M
    J Biol Chem; 1984 Oct; 259(19):11763-70. PubMed ID: 6237102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding domain for laminin on type IV collagen.
    Rao CN; Margulies IM; Liotta LA
    Biochem Biophys Res Commun; 1985 Apr; 128(1):45-52. PubMed ID: 3921025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of cell-surface heparin/heparan sulfate-binding proteins of a human uterine epithelial cell line (RL95).
    Raboudi N; Julian J; Rohde LH; Carson DD
    J Biol Chem; 1992 Jun; 267(17):11930-9. PubMed ID: 1601862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanisms in basement membrane complications of diabetes. Alterations in heparin, laminin, and type IV collagen association.
    Tarsio JF; Reger LA; Furcht LT
    Diabetes; 1988 May; 37(5):532-9. PubMed ID: 3360214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions of basement membrane components.
    Woodley DT; Rao CN; Hassell JR; Liotta LA; Martin GR; Kleinman HK
    Biochim Biophys Acta; 1983 Dec; 761(3):278-83. PubMed ID: 6228259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.